|
S2-p
|
______MsSILPFtP
|
Upstream
|
|
0
|
1
|
|
|
|
|
|
SMAD2 (human)
|
______MsSILPFtP
|
S2-p
|
|
SMAD2 (mouse)
|
______MSSILPFtP
|
S2
|
|
SMAD2 (rat)
|
______MSSILPFtP
|
S2
|
|
SMAD2 (cow)
|
______MSSILPFTP
|
S2
|
|
|
T8-p
|
MsSILPFtPPVVkRL
|
Upstream
|
Downstream
|
3
|
29
|
|
|
|
Effects on Modified Protein
- activity, induced
- molecular association, regulation
- protein stabilization
|
|
Effects on Biological Processes:
|
|
|
Kinase, in vitro:
|
|
Putative in vivo kinases:
|
|
Treatment
- EGF
- ischemia
- LRRK2-IN-1
- nocodazole
- U0126
|
|
|
SMAD2 (human)
|
MsSILPFtPPVVkRL
|
T8-p
|
|
SMAD2 (mouse)
|
MSSILPFtPPVVKRL
|
T8-p
|
|
SMAD2 (rat)
|
MSSILPFtPPVVKRL
|
T8-p
|
|
SMAD2 (cow)
|
MSSILPFTPPVVKRL
|
T8
|
|
|
K13-ub
|
PFtPPVVkRLLGWkk
|
|
|
0
|
4
|
|
|
|
SMAD2 (human)
|
PFtPPVVkRLLGWkk
|
K13-ub
|
|
SMAD2 (mouse)
|
PFtPPVVKRLLGWKK
|
K13
|
|
SMAD2 (rat)
|
PFtPPVVKRLLGWKK
|
K13
|
|
SMAD2 (cow)
|
PFTPPVVKRLLGWKK
|
K13
|
|
|
K19-ac
|
VkRLLGWkksAGGSG
|
Upstream
|
Downstream
|
3
|
5
|
|
|
|
Effects on Modified Protein
- intracellular localization
- molecular association, regulation
- protein conformation
|
|
Effects on Biological Processes:
- cell cycle regulation
- cell growth, inhibited
- signaling pathway regulation
- transcription, induced
|
|
|
Treatment
- anacardic acid
- siRNA
- TGF-beta
- trichostatin_A
|
|
|
SMAD2 (human)
|
VkRLLGWkksAGGSG
|
K19-ac
|
|
SMAD2 (mouse)
|
VKRLLGWKKSAGGSG
|
K19
|
|
SMAD2 (rat)
|
VKRLLGWKKSAGGSG
|
K19
|
|
SMAD2 (cow)
|
VKRLLGWKKSAGGSG
|
K19
|
|
|
K20-ac
|
kRLLGWkksAGGSGG
|
Upstream
|
Downstream
|
2
|
1
|
|
|
|
Effects on Modified Protein
- intracellular localization
|
|
Effects on Biological Processes:
- cell cycle regulation
- cell growth, inhibited
- signaling pathway regulation
- transcription, induced
|
|
|
Treatment
- siRNA
- TGF-beta
- trichostatin_A
|
|
|
SMAD2 (human)
|
kRLLGWkksAGGSGG
|
K20-ac
|
|
SMAD2 (mouse)
|
KRLLGWKKSAGGSGG
|
K20
|
|
SMAD2 (rat)
|
KRLLGWKKSAGGSGG
|
K20
|
|
SMAD2 (cow)
|
KRLLGWKKSAGGSGG
|
K20
|
|
|
S21-p
|
RLLGWkksAGGSGGA
|
|
|
0
|
1
|
|
|
|
SMAD2 (human)
|
RLLGWkksAGGSGGA
|
S21-p
|
|
SMAD2 (mouse)
|
RLLGWKKSAGGSGGA
|
S21
|
|
SMAD2 (rat)
|
RLLGWKKSAGGSGGA
|
S21
|
|
SMAD2 (cow)
|
RLLGWKKSAGGSGGA
|
S21
|
|
|
K39-ac
|
EQNGQEEkWCEKAVK
|
Upstream
|
Downstream
|
2
|
1
|
|
|
|
Effects on Modified Protein
- intracellular localization
|
|
Effects on Biological Processes:
- cell cycle regulation
- cell growth, inhibited
- signaling pathway regulation
- transcription, induced
|
|
|
Treatment
- siRNA
- TGF-beta
- trichostatin_A
|
|
|
SMAD2 (human)
|
EQNGQEEkWCEKAVK
|
K39-ac
|
|
SMAD2 (mouse)
|
EQNGQEEKWCEKAVK
|
K39
|
|
SMAD2 (rat)
|
EQNGQEEKWCEKAVK
|
K39
|
|
SMAD2 (cow)
|
EQNGQEEKWCEKAVK
|
K39
|
|
|
K63-ub
|
GRLDELEkAITTQNC
|
|
|
0
|
1
|
|
|
|
SMAD2 (human)
|
GRLDELEkAITTQNC
|
K63-ub
|
|
SMAD2 (mouse)
|
GRLDELEKAITTQNC
|
K63
|
|
SMAD2 (rat)
|
GRLDELEKAITTQNC
|
K63
|
|
SMAD2 (cow)
|
GRLDELEKAITTQNC
|
K63
|
|
|
Y102-p
|
QWDTTGLySFSEQTR
|
|
|
0
|
14
|
|
|
|
SMAD2 (human)
|
QWDTTGLySFSEQTR
|
Y102-p
|
|
SMAD2 (mouse)
|
QWDTTGLySFSEQTR
|
Y102-p
|
|
SMAD2 (rat)
|
QWDTTGLYSFSEQTR
|
Y102
|
|
SMAD2 (cow)
|
QWDTTGLYSFSEQTR
|
Y102
|
|
|
S110-p
|
SFSEQTRsLDGRLQV
|
Upstream
|
Downstream
|
1
|
0
|
|
|
|
Effects on Modified Protein
- intracellular localization
- molecular association, regulation
|
|
|
Kinase, in vitro:
|
|
Putative in vivo kinases:
|
|
|
SMAD2 (human)
|
SFSEQTRsLDGRLQV
|
S110-p
|
|
SMAD2 (mouse)
|
SFSEQTRSLDGRLQV
|
S110
|
|
SMAD2 (rat)
|
SFSEQTRSLDGRLQV
|
S110
|
|
SMAD2 (cow)
|
SFSEQTRSLDGRLQV
|
S110
|
|
|
K156-ub
|
CEYAFNLkkDEVCVN
|
|
|
0
|
1
|
|
|
|
SMAD2 (human)
|
CEYAFNLkkDEVCVN
|
K156-ub
|
|
SMAD2 (mouse)
|
CEYAFNLKKDEVCVN
|
K156
|
|
SMAD2 (rat)
|
CEYAFSLKKDEVCVN
|
K156
|
|
SMAD2 (cow)
|
CEYAFNLKKDEVCVN
|
K156
|
|
|
K156-sm
|
CEYAFNLkkDEVCVN
|
|
|
0
|
1
|
|
|
|
SMAD2 (human)
|
CEYAFNLkkDEVCVN
|
K156-sm
|
|
SMAD2 (mouse)
|
CEYAFNLKKDEVCVN
|
K156
|
|
SMAD2 (rat)
|
CEYAFSLKKDEVCVN
|
K156
|
|
SMAD2 (cow)
|
CEYAFNLKKDEVCVN
|
K156
|
|
|
K157-ub
|
EYAFNLkkDEVCVNP
|
|
|
0
|
1
|
|
|
|
SMAD2 (human)
|
EYAFNLkkDEVCVNP
|
K157-ub
|
|
SMAD2 (mouse)
|
EYAFNLKKDEVCVNP
|
K157
|
|
SMAD2 (rat)
|
EYAFSLKKDEVCVNP
|
K157
|
|
SMAD2 (cow)
|
EYAFNLKKDEVCVNP
|
K157
|
|
|
T172-p
|
YHYQRVEtPVLPPVL
|
|
|
0
|
8
|
|
|
|
SMAD2 (human)
|
YHYQRVEtPVLPPVL
|
T172-p
|
|
SMAD2 (mouse)
|
YHYQRVEtPVLPPVL
|
T172-p
|
|
SMAD2 (rat)
|
YHYQRVETPVLPPVL
|
T172
|
|
SMAD2 (cow)
|
YHYQRVETPVLPPVL
|
T172
|
|
|
T197-p
|
LPPLDDYtHSIPENT
|
Upstream
|
|
1
|
0
|
|
|
|
|
|
SMAD2 (human)
|
LPPLDDYtHSIPENT
|
T197-p
|
|
SMAD2 (mouse)
|
LPPLDDYTHSIPENT
|
T197
|
|
SMAD2 (rat)
|
LPPLDDYTHSIPENT
|
T197
|
|
SMAD2 (cow)
|
LPPLDDYTHSIPENT
|
T197
|
|
|
T220-p
|
QSNYIPEtPPPGYIS
|
Upstream
|
Downstream
|
12
|
0
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
- protein stabilization
|
|
Effects on Biological Processes:
- carcinogenesis, induced
- cell differentiation, induced
- signaling pathway regulation
- transcription, induced
|
|
|
Kinase, in vitro:
- ERK1 (human)
- ERK2 (human)
- OSR1 (human)
|
|
Putative in vivo kinases:
- ERK1 (human)
- OSR1 (human)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- FOXO4 (human)
- HRas (human)
- MEK1 (human)
- NEDD4L (human)
- TGFB1 (human)
|
|
Treatment
- alvocidib
- BMP2
- EGF
- MG132
- PD98059
- SB203580
- siRNA
- TGF-beta
- wortmannin
- Y27632
|
|
|
SMAD2 (human)
|
QSNYIPEtPPPGYIS
|
T220-p
|
|
SMAD2 (mouse)
|
QSNYIPETPPPGYIS
|
T220
|
|
SMAD2 (rat)
|
QSNYIPETPPPGYIS
|
T220
|
|
SMAD2 (cow)
|
QSNYIPEtPPPGYIS
|
T220-p
|
|
|
S240-p
|
SDQQLNQsMDTGsPA
|
Upstream
|
Downstream
|
2
|
0
|
|
|
|
Effects on Modified Protein
- intracellular localization
- molecular association, regulation
|
|
|
Kinase, in vitro:
|
|
Putative in vivo kinases:
|
|
Treatment
- decorin
- EGF
- KN-93
- TGF-beta
|
|
|
SMAD2 (human)
|
SDQQLNQsMDTGsPA
|
S240-p
|
|
SMAD2 (mouse)
|
SDQQLNQSMDTGsPA
|
S240
|
|
SMAD2 (rat)
|
SDQQLNQSMDTGSPA
|
S240
|
|
SMAD2 (cow)
|
SDQQLNQSMDTGsPA
|
S240
|
|
|
S245-p
|
NQsMDTGsPAELsPT
|
Upstream
|
Downstream
|
12
|
0
|
|
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
- protein conformation
- protein stabilization
|
|
Effects on Biological Processes:
- cell differentiation, induced
- cell motility, altered
- transcription, induced
|
|
|
Kinase, in vitro:
- ERK1 (human)
- ERK2 (human)
- MELK (mouse)
|
|
Putative in vivo kinases:
- CDK2 (human)
- ERK1 (human)
- MELK (mouse)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- HRas (human)
- KLF2 (human)
- MEK1 (human)
- MEKK3 (human)
- SETD2 (human)
|
|
Treatment
- alvocidib
- AT7519
- AZD4573
- EGF
- exercise
- flavopiridol
- fluid_shear_stress
- hypoxia
- lncRNAs
- LY2109761
- LY294002
- PD98059
- SB202190
- SB431542
- siRNA
- TGF-beta
- U0126
- wortmannin
|
|
|
SMAD2 (human)
|
NQsMDTGsPAELsPT
|
S245-p
|
|
SMAD2 (mouse)
|
NQSMDTGsPAELSPT
|
S245-p
|
|
SMAD2 (rat)
|
NQSMDTGSPAELSPT
|
S245
|
|
SMAD2 (cow)
|
NQSMDTGsPAELsPT
|
S245-p
|
|
|
S250-p
|
TGsPAELsPTTLsPV
|
Upstream
|
Downstream
|
11
|
1
|
|
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
- phosphorylation
- protein conformation
- protein degradation
- protein stabilization
|
|
Effects on Biological Processes:
- cell differentiation, induced
- cell growth, induced
- cell motility, altered
- cell motility, inhibited
- signaling pathway regulation
- transcription, induced
- transcription, inhibited
|
|
|
Kinase, in vitro:
- ERK1 (human)
- ERK2 (human)
- NLK (human)
|
|
Putative in vivo kinases:
- CDK2 (human)
- ERK1 (human)
- NLK (human)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- HRas (human)
- KLF2 (human)
- MEK1 (human)
- MEKK3 (human)
- SETD2 (human)
|
|
Treatment
- AT7519
- AZD4573
- EGF
- exercise
- flavopiridol
- fluid_shear_stress
- hypoxia
- lncRNAs
- LY2109761
- PD98059
- siRNA
- TGF-beta
- U0126
- wortmannin
|
|
|
SMAD2 (human)
|
TGsPAELsPTTLsPV
|
S250-p
|
|
SMAD2 (mouse)
|
TGsPAELSPTTLSPV
|
S250
|
|
SMAD2 (rat)
|
TGSPAELSPTTLSPV
|
S250
|
|
SMAD2 (cow)
|
TGsPAELsPTTLsPV
|
S250-p
|
|
|
S255-p
|
ELsPTTLsPVNHsLD
|
Upstream
|
Downstream
|
10
|
0
|
|
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
- protein conformation
- protein stabilization
|
|
Effects on Biological Processes:
- cell differentiation, induced
- cell motility, altered
- transcription, induced
|
|
|
Kinase, in vitro:
- ERK1 (human)
- ERK2 (human)
|
|
Putative in vivo kinases:
- CDK2 (human)
- ERK1 (human)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- HRas (human)
- KLF2 (human)
- MEK1 (human)
- MEKK3 (human)
- SETD2 (human)
|
|
Treatment
- alvocidib
- AT7519
- AZD4573
- EGF
- exercise
- flavopiridol
- fluid_shear_stress
- hypoxia
- lncRNAs
- LY2109761
- LY294002
- PD98059
- SB202190
- siRNA
- TGF-beta
- U0126
- wortmannin
|
|
|
SMAD2 (human)
|
ELsPTTLsPVNHsLD
|
S255-p
|
|
SMAD2 (mouse)
|
ELSPTTLSPVNHSLD
|
S255
|
|
SMAD2 (rat)
|
ELSPTTLSPVNHSLD
|
S255
|
|
SMAD2 (cow)
|
ELsPTTLsPVNHSLD
|
S255-p
|
|
|
S260-p
|
TLsPVNHsLDLQPVT
|
Upstream
|
Downstream
|
1
|
0
|
|
|
|
Effects on Modified Protein
- intracellular localization
- molecular association, regulation
|
|
|
Kinase, in vitro:
|
|
Putative in vivo kinases:
|
|
|
SMAD2 (human)
|
TLsPVNHsLDLQPVT
|
S260-p
|
|
SMAD2 (mouse)
|
TLSPVNHSLDLQPVT
|
S260
|
|
SMAD2 (rat)
|
TLSPVNHSLDLQPVT
|
S260
|
|
SMAD2 (cow)
|
TLsPVNHSLDLQPVT
|
S260
|
|
|
T324-p
|
SNVNRNAtVEMTRRH
|
|
|
1
|
1
|
|
|
|
SMAD2 (human)
|
SNVNRNAtVEMTRRH
|
T324-p
|
|
SMAD2 (mouse)
|
SNVNRNAtVEMTRRH
|
T324-p
|
|
SMAD2 (rat)
|
SNVNRNATVEMTRRH
|
T324
|
|
SMAD2 (cow)
|
SNVNRNATVEMTRRH
|
T324
|
|
|
S417-p
|
RMCTIRMsFVkGWGA
|
Upstream
|
Downstream
|
1
|
1
|
|
|
|
Effects on Modified Protein
- molecular association, regulation
|
|
Effects on Biological Processes:
- signaling pathway regulation
- transcription, inhibited
|
|
|
Kinase, in vitro:
|
|
Putative in vivo kinases:
|
|
Treatment
|
|
|
SMAD2 (human)
|
RMCTIRMsFVkGWGA
|
S417-p
|
|
SMAD2 (mouse)
|
RMCTIRMSFVKGWGA
|
S417
|
|
SMAD2 (rat)
|
RMCTIRMSFVKGWGA
|
S417
|
|
SMAD2 (cow)
|
RMCTIRMSFVKGWGA
|
S417
|
|
|
K420-ac
|
TIRMsFVkGWGAEYR
|
|
|
0
|
4
|
|
|
|
SMAD2 (human)
|
TIRMsFVkGWGAEYR
|
K420-ac
|
|
SMAD2 (mouse)
|
TIRMSFVKGWGAEYR
|
K420
|
|
SMAD2 (rat)
|
TIRMSFVKGWGAEYR
|
K420
|
|
SMAD2 (cow)
|
TIRMSFVKGWGAEYR
|
K420
|
|
|
S433
|
YRRQTVTSTPCWIEL
|
|
|
1
|
0
|
|
|
|
SMAD2 (human)
|
YRRQTVTSTPCWIEL
|
S433
|
|
SMAD2 (mouse)
|
YRRQTVTsTPCWIEL
|
S433-p
|
|
SMAD2 (rat)
|
YRRQTVTSTPCWIEL
|
S433
|
|
SMAD2 (cow)
|
YRRQTVTSTPCWIEL
|
S433
|
|
|
K451-ac
|
GPLQWLDkVLTQMGs
|
|
Downstream
|
1
|
0
|
|
|
|
Effects on Modified Protein
- intracellular localization
- protein stabilization
|
|
|
SMAD2 (human)
|
GPLQWLDkVLTQMGs
|
K451-ac
|
|
SMAD2 (mouse)
|
GPLQWLDKVLTQMGs
|
K451
|
|
SMAD2 (rat)
|
GPLQWLDKVLTQMGS
|
K451
|
|
SMAD2 (cow)
|
GPLQWLDKVLTQMGS
|
K451
|
|
|
S458-p
|
kVLTQMGsPsVRCss
|
Upstream
|
|
0
|
12
|
|
|
|
|
|
SMAD2 (human)
|
kVLTQMGsPsVRCss
|
S458-p
|
|
SMAD2 (mouse)
|
KVLTQMGsPSVRCSs
|
S458-p
|
|
SMAD2 (rat)
|
KVLTQMGSPSVRCSs
|
S458
|
|
SMAD2 (cow)
|
KVLTQMGSPSVRCSS
|
S458
|
|
|
S460-p
|
LTQMGsPsVRCssMs
|
Upstream
|
|
0
|
3
|
|
|
|
|
|
SMAD2 (human)
|
LTQMGsPsVRCssMs
|
S460-p
|
|
SMAD2 (mouse)
|
LTQMGsPSVRCSsMs
|
S460
|
|
SMAD2 (rat)
|
LTQMGSPSVRCSsMs
|
S460
|
|
SMAD2 (cow)
|
LTQMGSPSVRCSSMS
|
S460
|
|
|
S464-p
|
GsPsVRCssMs____
|
Upstream
|
Downstream
|
5
|
2
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
|
|
Effects on Biological Processes:
- transcription, altered
- transcription, induced
|
|
|
Kinase, in vitro:
- PAK2 (human)
- TGFBR1 (human)
|
|
Putative in vivo kinases:
- BMPR1B (human)
- TGFBR1 (human)
|
|
Treatment
|
|
|
SMAD2 (human)
|
GsPsVRCssMs____
|
S464-p
|
|
SMAD2 (mouse)
|
GsPSVRCSsMs____
|
S464
|
|
SMAD2 (rat)
|
GSPSVRCSsMs____
|
S464
|
|
SMAD2 (cow)
|
GSPSVRCSSMS____
|
S464
|
|
|
S465-p
|
sPsVRCssMs_____
|
Upstream
|
Downstream
|
66
|
6
|
|
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
|
|
Effects on Biological Processes:
- carcinogenesis, induced
- cell differentiation, induced
- transcription, altered
- transcription, induced
|
|
|
Kinase, in vitro:
- PAK2 (human)
- TGFBR1 (human)
|
|
Putative in vivo kinases:
- BMPR1B (human)
- TGFBR1 (human)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- Akt1 (human)
- ALK (human)
- BORIS (human)
- CCNC (human)
- CDK8 (human)
- FURIN (human)
- GDF11 (human)
- GRK2 (human)
- HTRA1 (human)
- ITGAV (human)
- ITGB5 (human)
- Lmr2 (human)
- MED12 (human)
- MED7 (human)
- MSTN (human)
- MURF1 (human)
- PPM1B (human)
- PTPRK (human)
- RHEB (human)
- SETD2 (human)
- SMAD4 (human)
- SMAD7 (human)
- SOX6 (human)
- STMP1 (human)
- TGFBR1 (human)
- TSC1 (human)
- Vimentin (human)
- YAP1 (human)
|
|
Treatment
- 5(S)-HETE
- activin
- AG538
- ALK5_Inhibitor_I
- angiotensin_2
- antibody
- ascorbic_acid
- caffeic_acid
- CRM197
- decorin
- EGF
- enzalutamide
- eribulin
- FGF2
- gefitinib
- heregulin
- hyaluronan
- IGF-1
- IL-6
- insulin
- ITD-1
- lncRNAs
- LY294002
- masoprocol
- Nodal
- oncostatin_M
- picropodophyllin
- rapamycin
- SB202190
- SB203580
- SB431542
- siRNA
- starvation_medium
- TGF-beta
- U0126
- UV
- Y27632
|
|
|
SMAD2 (human)
|
sPsVRCssMs_____
|
S465-p
|
|
SMAD2 (mouse)
|
sPSVRCSsMs_____
|
S465-p
|
|
SMAD2 (rat)
|
SPSVRCSsMs_____
|
S465-p
|
|
SMAD2 (cow)
|
SPSVRCSSMS_____
|
S465
|
|
|
S467-p
|
sVRCssMs_______
|
Upstream
|
Downstream
|
66
|
6
|
|
|
|
|
|
Effects on Modified Protein
- activity, induced
- intracellular localization
- molecular association, regulation
|
|
Effects on Biological Processes:
- carcinogenesis, induced
- cell differentiation, induced
- transcription, altered
- transcription, induced
|
|
|
Kinase, in vitro:
- PAK2 (human)
- TGFBR1 (human)
|
|
Putative in vivo kinases:
- BMPR1B (human)
- TGFBR1 (human)
|
|
Putative upstream phosphatases:
|
|
Regulatory protein:
- Akt1 (human)
- ALK (human)
- BORIS (human)
- CCNC (human)
- CDK8 (human)
- FURIN (human)
- GDF11 (human)
- GRK2 (human)
- HTRA1 (human)
- ITGAV (human)
- ITGB5 (human)
- Lmr2 (human)
- MED12 (human)
- MED7 (human)
- MSTN (human)
- MURF1 (human)
- PPM1B (human)
- PTPRK (human)
- RHEB (human)
- SETD2 (human)
- SMAD4 (human)
- SMAD7 (human)
- SOX6 (human)
- STMP1 (human)
- TGFBR1 (human)
- TSC1 (human)
- Vimentin (human)
- YAP1 (human)
|
|
Treatment
- 5(S)-HETE
- activin
- AG538
- ALK5_Inhibitor_I
- angiotensin_2
- antibody
- ascorbic_acid
- caffeic_acid
- CRM197
- decorin
- EGF
- enzalutamide
- eribulin
- FGF2
- gefitinib
- heregulin
- hyaluronan
- IGF-1
- IL-6
- insulin
- ITD-1
- lncRNAs
- LY294002
- masoprocol
- Nodal
- oncostatin_M
- picropodophyllin
- rapamycin
- SB202190
- SB203580
- SB431542
- siRNA
- starvation_medium
- TGF-beta
- U0126
- UV
- Y27632
|
|
|
SMAD2 (human)
|
sVRCssMs_______
|
S467-p
|
|
SMAD2 (mouse)
|
SVRCSsMs_______
|
S467-p
|
|
SMAD2 (rat)
|
SVRCSsMs_______
|
S467-p
|
|
SMAD2 (cow)
|
SVRCSSMS_______
|
S467
|
|
